Final Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOA
Werte in diesem Artikel
LOS ANGELES, March 10, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against BioAge Labs, Inc. ("BioAge" or "the Company") (NASDAQ: BIOA) for violations of the federal securities laws.
Shareholders who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering ("IPO") conducted on September 26, 2024, are encouraged to contact the firm before March 10, 2025.
CASE DETAILS: According to the Complaint, BioAge allegedly made false and misleading statements to the market when it announced on December 6, 2024, that it would discontinue its ongoing STRIDES Phase 2 trial of its lead trial candidate, azelaprag. The Company cited safety concerns in participants as the reason for the discontinuation, contrary to its claims during the IPO that azelaprag had potential in patients in obesity therapy with incretin drugs.
If you are a shareholder who suffered a loss, contact us to participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/final-deadline-for-the-bioage-labs-inc-securities-lawsuit---contact-the-djs-law-group-to-discuss-your-rights---bioa-302396627.html
SOURCE DJS Law Group LLP
Ausgewählte Hebelprodukte auf BioAge Labs
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf BioAge Labs
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu BioAge Labs Inc Registered Shs
Analysen zu BioAge Labs Inc Registered Shs
Keine Analysen gefunden.